Key result
MHCII deficiency increases aortic atherosclerosis ~150% via regulatory T-cell loss.
Why the study?
Does MHCII deficiency aggravate atherosclerosis in ApoE-/- mice?
Population
Apolipoprotein E (ApoE-/-) mice
Comparison
Deficiency for major histocompatibility complex… vs ApoE-/- mice with intact MHCII
Design
Preclinical
Authors
Loading...
Antigen presentation on MHCII has protective functions in atherosclerosis, primarily through activation of regulatory T cells, suggesting potential cardiovascular risks associated with immunosuppressive therapy.
Does MHCII deficiency aggravate atherosclerosis in ApoE-/- mice?
Absolute Event Rate: 4.7% vs 1.9%
p-value: p=<0.01
Antigen presentation on MHCII has protective functions in atherosclerosis, primarily through activation of regulatory T cells, suggesting potential cardiovascular risks associated with immunosuppressive therapy.
Wigren et al. (2019) studied Atherosclerosis. MHCII deficiency vs. ApoE −/− mice was evaluated on Atherosclerosis as assessed by en face Oil Red O staining of the aorta (p=<0.01). MHCII deficiency in ApoE −/− mice significantly aggravated atherosclerosis, increasing aortic lesion area from 1.9% to 4.7% (P<0.01), primarily due to the loss of regulatory T cells.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: